{
  "actions": [
    {
      "acted_at": "2009-10-22", 
      "committee": "Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2009-10-22", 
      "committee": "House Energy and Commerce", 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2009-10-22", 
      "committee": "House Ways and Means", 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2009-10-23", 
      "in_committee": "House Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3917-111", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "111", 
  "cosponsors": [
    {
      "district": "16", 
      "name": "Pitts, Joseph R.", 
      "sponsored_at": "2009-10-22", 
      "state": "PA", 
      "thomas_id": "01514", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2009-10-22", 
  "number": "3917", 
  "official_title": "To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medicare Nuclear Medicine Payment Group Clarification Act of 2009", 
  "sponsor": {
    "district": "1", 
    "name": "Stupak, Bart", 
    "state": "MI", 
    "thomas_id": "01123", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2009-10-22", 
  "subjects": [
    "Drug and radiation therapy", 
    "Health", 
    "Health care costs and insurance", 
    "Home and outpatient care", 
    "Medical tests and diagnostic methods", 
    "Medicare"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2009-10-22", 
    "text": "Medicare Nuclear Medicine Payment Group Clarification Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act to revise requirements for treatment of certain costs for a nuclear medicine group in the prospective payment system (PPS) for hospital outpatient department services. Declares that services classified within a nuclear medicine group shall not be treated as comparable with respect to the use of resources, and therefore shall be excluded from the group, if the highest median cost (or, at the Secretary's election, mean cost) of any associated diagnostic radiopharmaceutical included in the payment for the service within the group is more than two times greater than the lowest median cost (or mean cost, if so elected) for a service within the group."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Medicare Nuclear Medicine Payment Group Clarification Act of 2009", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T23:47:27-04:00"
}